Comprehensive Geriatric Assessment for Postoperative Delirium
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the best method to reduce confusion and concentration problems (delirium) in frail, older patients after surgery. It compares two approaches: one involves a specialist in elderly care regularly checking in with patients (Comprehensive Geriatric Assessment, or CGA), and the other involves doctors noting the patient's frailty in their electronic records. Participants should have at least two conditions, such as needing help with daily tasks, recent heart issues, or chronic breathing problems, and they should plan to undergo surgery requiring an overnight hospital stay. As an unphased trial, this study allows participants to contribute to valuable research that could enhance post-surgery care for older adults.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this protocol is safe for frail, older patients undergoing surgery?
Research has shown that a Comprehensive Geriatric Assessment (CGA) can lower the risk of confusion or delirium in older adults after surgery. Previous studies found that CGA reduces the chance of delirium by about 8%. For every 13 people who receive CGA, one person might avoid experiencing delirium.
These studies reported no serious safety issues. CGA involves a thorough check-up by a doctor specializing in the care of older adults. This method is considered safe and aims to support the health of frail, older patients.12345Why are researchers excited about this trial?
Researchers are excited about the Comprehensive Geriatric Assessment (CGA) for postoperative delirium because it offers a tailored approach to elderly patients after surgery. Unlike the standard of care, which typically involves general medical management and monitoring, CGA provides a thorough evaluation of a patient’s health, including physical, psychological, and social aspects. This personalized assessment aims to identify specific risks and needs, potentially leading to better prevention and management of delirium. By focusing on the whole patient rather than just the symptoms, CGA could improve recovery outcomes and enhance overall quality of life for older adults.
What evidence suggests that this method is effective for reducing postoperative delirium?
Research has shown that a Comprehensive Geriatric Assessment (CGA), which participants in this trial may receive, can reduce confusion and concentration difficulties after surgery in older adults. Studies have demonstrated that CGA lowered the rate of these issues from 37% to 28.5%, meaning fewer people experienced these problems post-surgery. CGA involves a thorough check-up by a geriatrician, a doctor specializing in the care of older adults. Specifically, the research found an 8.28% absolute risk reduction, indicating that for every 13 people who received CGA, one case of confusion was prevented. This evidence suggests that CGA is a promising method to reduce these issues in frail, older patients after surgery.15678
Who Is on the Research Team?
Elizabeth Gabrielli, MD
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for frail, older patients who are scheduled for planned surgery. It aims to see if a detailed evaluation by a Geriatrician after surgery can better reduce the risk of delirium compared to just noting the patient's frailty in their medical records.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the CGA intervention or standard care for up to 2 weeks
Follow-up
Participants are monitored for postoperative delirium and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- CGA
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
Anesthesia Patient Safety Foundation (APSF)
Collaborator